HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy.

AbstractPURPOSE:
Vesicular glutamate transporters (VGLUTs) are responsible for loading synaptic vesicles with glutamate, determining the phenotype of glutamatergic neurons, and have been implicated in the regulation of quantal size and presynaptic plasticity. We analyzed VGLUT subtype expression in normal human hippocampus and tested the hypothesis that alterations in VGLUT expression may contribute to long-term changes in glutamatergic transmission reported in patients with temporal lobe epilepsy (TLE).
METHODS:
VGLUT immunohistochemistry, immunofluorescence, in situ hybridization, Western blotting, and quantitative polymerase chain reaction (qPCR) were performed on biopsies from TLE patients without (non-HS) and with hippocampal sclerosis (HS) and compared to autopsy controls and rat hippocampus. VGLUT1 expression was compared with synaptophysin, neuropeptide Y (NPY), and Timm's staining.
RESULTS:
VGLUT1 was the predominant VGLUT in human hippocampus and appeared to be localized to presynaptic glutamatergic terminals. In non-HS hippocampi, VGLUT1 protein levels were increased compared to control and HS hippocampi in all subfields. In HS hippocampi VGLUT1 expression was decreased in subfields with severe neuronal loss, but strongly up-regulated in the dentate gyrus, characterized by mossy fiber sprouting.
DISCUSSION:
VGLUT1 is used as marker for glutamatergic synapses in the human hippocampus. In HS hippocampi VGLUT1 up-regulation in the dentate gyrus probably marks new glutamatergic synapses formed by mossy fiber sprouting. Our data indicate that non-HS patients have an increased capacity to store glutamate in vesicles, most likely due to an increase in translational processes or upregulation of VGLUT1 in synapses from afferent neurons outside the hippocampus. This up-regulation may increase glutamatergic transmission, and thus contribute to increased extracellular glutamate levels and hyperexcitability.
AuthorsW Saskia van der Hel, Suzanne A M W Verlinde, Dimphna H M Meijer, Marina de Wit, Marije G Rensen, Koen L I van Gassen, Peter C van Rijen, Cees W M van Veelen, Pierre N E de Graan
JournalEpilepsia (Epilepsia) Vol. 50 Issue 7 Pg. 1717-28 (Jul 2009) ISSN: 1528-1167 [Electronic] United States
PMID19389151 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neuropeptide Y
  • Synaptophysin
  • Vesicular Glutamate Transport Protein 1
  • Glutamic Acid
Topics
  • Animals
  • Dentate Gyrus (metabolism)
  • Epilepsy, Temporal Lobe (metabolism, pathology, physiopathology)
  • Glutamic Acid (metabolism)
  • Hippocampus (metabolism, pathology, physiopathology)
  • Humans
  • Immunohistochemistry
  • Mossy Fibers, Hippocampal (metabolism, pathology)
  • Neurons (metabolism, pathology)
  • Neuropeptide Y (metabolism)
  • Rats
  • Sclerosis (pathology)
  • Synapses (metabolism, pathology, physiology)
  • Synaptic Vesicles (metabolism, pathology)
  • Synaptophysin (metabolism)
  • Tissue Distribution
  • Vesicular Glutamate Transport Protein 1 (metabolism, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: